4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-011258
SVP, COO & CFO sold 5,938 shares at $22.35 ($132,714)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2020-02-18 | Sale | −5,938 | $22.35 | $132,714 | 253,221 | D: show line 1 in the form |
| Open-market sales · 5,938 sh · avg $22.35 · $132,714 | |||||||
Loading xslF345X03/doc4.xml…